A national study from Michigan Medicine shows that the use of these weight loss drugs is increasing rapidly in adolescents and young adults 12-25 years, especially females.

A JAMA viewpoint outlines the tragic story of Shandra Eisenga, a patient who received spine surgery for back pain only to inexplicably contract tuberculosis.

Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment

At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests

Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new study.

Through a $4.17M NIH grant, a team of biomedical engineers, medical clinicians and data scientists from the Max Harry Weil Institute for Critical Care Research and Innovation is collaboratively researching ways to develop a portable, non-invasive breathalyzer-type device and corresponding algorithm to quickly and accurately diagnose acute respiratory distress syndrome (ARDS).

A Michigan Medicine-led study found that transgender individuals show similar rates of severe parental morbidity and preterm birth and lower rates of cesarean delivery when compared to cisgender people.

Mallory Mattison serves as the inspiration behind critical medical research that’s supporting other patients like her with lipodystrophy syndromes

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

Teams from Vanderbilt University Medical Center and the University of Michigan design a comprehensive study that integrates multiple analytic approaches that has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to type 2 diabetes.

Research at Michigan Medicine has been working to improve the psychosocial concerns related to diabetes, which often pose issues for people living with the condition

A physician invents a creative approach for medical students in diabetic care.

Living with diabetes at such a young age comes with challenges, but those challenges have inspired Jackson, now 8 years old, to come up with ways for people like him to live a little easier with a new device called "SensePod".

Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite called GTP controls responses to radiation and chemotherapy in an unexpected way.